Understanding Als Drug Development Roundtable
Exploring Als Drug Development Roundtable reveals several interesting facts. Richard Bedlack, MD, PhD, from Duke University moderates the
Key Takeaways about Als Drug Development Roundtable
- Jinsy Andrews, director of neuromuscular clinical trials at Columbia University Irving Medical Center, discusses the unique ...
- Moderated by Gil I. Wolfe, MD, FAAN, University at Buffalo. The MDA Engage Virtual Myasthenia Gravis Symposium was held on ...
- Elise Qvale from MDA moderates the
- Moderated by Nancy L. Kuntz, MD, FAAN, Lurie Children's Hospital. The MDA Engage Spinal Muscular Atrophy symposium, ...
- Jeffrey Rothstein, director of the Robert Packard Center for
Detailed Analysis of Als Drug Development Roundtable
The Held on May 18th, 2023, part three of the MDA What will it take to develop reliable biomarkers for
In this Expert Talk, Dr. Olga Uspenskaya-Cadoz and Dr. James Berry introduce PIONEER-
Stay tuned for more updates related to Als Drug Development Roundtable.
